Immunobiology 219 (2014) 932–943
Contents lists available at ScienceDirect
Immunobiology
jo ur nal homep age: www.elsevier.com/locate/imbio
Role of Fas/FasL signaling in regulation of anti-viral response during
HSV-2 vaginal infection in mice
Malgorzata Krzyzowska
a,b,∗
, Piotr Orłowski
a
, Piotr B˛ aska
b
, Pawel Bodera
a
,
Robert Zdanowski
a
, Wanda Stankiewicz
a
a
Military Institute of Hygiene and Epidemiology, Warsaw, Poland
b
Department of Preclinical Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
a r t i c l e i n f o
Article history:
Received 18 February 2014
Received in revised form 29 June 2014
Accepted 29 July 2014
Available online 5 August 2014
Keywords:
Fas/FasL
HSV-2
Tregs
Dendritic cells
IL-10
a b s t r a c t
Fas receptor–Fas ligand (FasL) signaling is involved in apoptosis of virus-infected cells but increasing evi-
dence accumulates on Fas receptor as a mediator of apoptosis-independent processes such as induction of
activating and pro-inflammatory signals. In this study, we examined the role of Fas/FasL pathway in reg-
ulation of anti-viral response to genital HSV-2 infection using a murine model of HSV-2 infection applied
to C57BL6/J, B6. MRL-Faslpr/J and B6Smn.C3-Faslgld/J mice. HSV-2 infection of Fas- and FasL-deficient
mice led to decreased migration of IFN- expressing NK cells and CD4+ T cells, but not of T cells, into
the vaginal tissue. The vaginal tissues of HSV-2 infected Fas- and FasL-deficient mice showed increased
production of IL-10, followed by low expression of the early CD69 activation marker on CD4+ and CD8+ T
cells and increased numbers of regulatory T cells (Tregs). Experiments in co-cultures of CD4+ T cells and
bone marrow derived dendritic cells showed that lack of bilateral Fas–FasL signaling led to expansion of
Tregs and increased production of IL-10 and TGF-1. Our results demonstrate that Fas/FasL can regulate
development of tolerogenic dendritic cells and expansion of Tregs early during HSV-2 infection, which
further influences effective anti-viral response.
© 2014 Elsevier GmbH. All rights reserved.
Introduction
Fas (CD95; tumor necrosis factor receptor superfamily member
6, TNFRSF6) is a member of the death receptor (DR) family, a
subfamily of the tumor necrosis factor receptor superfamily.
Crosslinking of Fas with its natural ligand – FasL (CD95L, CD178)
or with agonistic antibodies induces apoptosis in sensitive cells.
Fas-induced apoptosis is involved in the cytotoxic activity of T cells
and NK cells (Davidson et al. 2002), peripheral B cell tolerance and
elimination of self-reactive T cells (Ju et al. 1995; Stranges et al.
2007). Fas can also induce non-apoptotic signaling resulting in cell
Abbreviations: BMDC, bone marrow derived dendritic cell; DC, dendritic cell;
HSV-2, herpes simplex virus type 2; IFN, interferon; MHC, major histocompatibility
complex; NK cells, natural killer cells; STD, sexually transmitted diseases; TCR, T-
cell receptor; TGF, transforming growth factor; TNF, tumor necrosis factor; TNFRSF6,
tumor necrosis factor receptor superfamily member 6; Tregs, regulatory T cells.
∗
Corresponding author. Present address: Department of Regenerative Medicine,
Military Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland.
Tel.: +48 501535456; fax: +48 226122718.
E-mail addresses: krzyzowskam@yahoo.com, malloba@gmail.com
(M. Krzyzowska).
proliferation, angiogenesis, fibrosis and inflammation (Mocellin
2010; Ramaswamy et al. 2009).
Herpes simplex virus type 2 (HSV-2) is a sexually transmitted
virus that gives rise to genital herpes. Epithelial cells and kerati-
nocytes are the primary target cells for HSV-2, but it also infects
peripheral neuronal and immune cells (Gupta et al. 2007; Whitley
2001). In the majority of infected individuals, the virus estab-
lishes latency in sacral ganglia, where it can be reactivated causing
recurrent genital disease (Gupta et al. 2007; Whitley 2001). Mul-
tiple cell types have been shown to contribute to the innate and
adaptive immune response to HSV-2 infection. Natural killer (NK)
cells are nonspecific innate cells, whose role in anti-HSV immu-
nity involves cytokine production (IFN-), recognition, and killing
of virally infected cells (Ashkar and Rosenthal 2003; Thapa et al.
2007). Another cell type – TCR + T cells have been shown to exert
a protective role against HSV type 1 infection in a mouse model
(Sciammas et al. 1997) and against intravaginal infection with
HSV-2 (Nishimura et al. 2004). However, other studies strongly sug-
gested that + T cells are not required for or involved in clearance
of HSV-2 from the genital epithelium (Milligan et al. 2004; Rakasz
et al. 1999).
The adaptive cellular response is highly involved in the anti-
HSV-2 defense, with CD8+ T cells producing IFN- and exerting
http://dx.doi.org/10.1016/j.imbio.2014.07.021
0171-2985/© 2014 Elsevier GmbH. All rights reserved.